Nuwellis Announces Appointment of Chief Financial Officer
(Minneapolis, MN) — Oct. 19, 2022 — Continuing its commitment to expanding access to life-saving ultrafiltration therapies for adult and pediatric patients suffering from fluid overload, Nuwellis, Inc. (Nasdaq: NUWE) today announced the appointment of Lynn Blake as Chief Financial Officer, effective October 19, 2022. “Nuwellis is entering our next phase of commercial development with significant new opportunities in heart failure, pediatrics and critical care. The deep knowledge and experience